Stimulants: epidemiology and impact on mental health

by Professor Fabrizio Schifano and Dr Antonio Albanese

Stimulants: epidemiology and impact on mental healthIn the second half of the 1990s, a global trend of escalating stimulant misuse was observed across a number of EU countries (stimulants such as cocaine, amphetamine, methamphetamine, methylenedioxymethamphetamine/MDMA, cathinone derivatives, benzylpiperazine/BZP).

 

When reorganising statutory and non-statutory services to cope with this increasingly widespread clinical issue, the epidemiological approach is of paramount importance, and a clear appreciation of the levels of stimulant misuse is necessary in order to allocate the appropriate levels of resources.

 

Stimulant misuse is typically associated with an imbalance of neurotransmitters, especially dopamine. Therefore, practising psychiatrists need to be aware of the psychopathological consequences related to substance misuse in order to refine their own diagnostic and clinical management skills.

 

Start the module

 

 

If you like this module, you may also be interested in:

 

Helping the addicted doctor by Dr Elizabeth Hare and Dr Malcolm Bruce

 

Substance misuse in older people by Dr Rahul Rao and Professor Ilana Crome

 

Drug Misuse: Psychosocial Interventions - The NICE Guideline (book from RCPsych publications)

 

Advances in Psychiatric Treatment: related articles for CPD Online

 

 

Related Advances articles

 

Download take-home notes to print and annotateDownload take-home notes to print and annotate

 

Module information | Module contents | About the authors | Take-home notes | Feedback 
© 2014 Royal College of Psychiatrists